Cost-effective wide-ranging pharmaceutical research with Semcon’s new specialist skills

Semcon is broadening its business and collaboration with the pharmaceutical industry by adding services aimed at pharmaceutical research and pre-clinical development. A new unit with specialist expertise in the field of pharmaceutical research’s various disciplines is already underway with a number of customer projects in project management and training.

Semcon’s Pharmaceutical & Biotech R&D business mainly targets the many small and mid-sized companies that run medical research and pharmaceutical development. These companies don’t have the possibility of having all the various specialist disciplines required internally and instead outsource to external experts. On a hourly basis, having access to specialist expertise with extensive industrial experience is an attractive and cost-effective alternative. Semcon has expertise in all areas of pre-clinical pharmaceutical development, giving the customer access to both individual expertise and entire teams, all according to their specific needs.

“Our expertise and extensive experience mean that we can help our customers decide where to make things more effective and still maintain the high quality needed to meet the authorities’ strict demands. We want to help customers make the right decisions, and make these decisions from the start,” says Katarina Beierlein, department manager at Pharma R&D. Katarina has 18 years’ experience of the pharmaceutical industry and came to Semcon from Biovitrum, where she was head of the Pharmaceutical Chemistry division.

Semcon’s offer includes services such as project planning, project management, specialist advice, outsourcing management and compiling documentation. Through our partners we also have access to laboratory functions and more “hands-on” services. Another target group includes investors through whom we can provide assistance with assessments ahead of investments and taking part in due diligence processes.

“During the spring the unit has helped customers design pre-clinical project plans, carried out training sessions in specialist areas and helped customers in other ways with development projects,” she concludes.

Sweden is currently the primary market, but Semcon’s international width and its niche in the field of Pharma R&D also mean that other markets will be included in future. The next thing on the agenda is a continued investment in Scandinavia and Northern Europe.



For more information, please contact:
Katarina Beierlein, Department manager, Pharma R&D +46 (0)739 171 379
Cecilia Norberg, Business Area manager, Medical Life Science, +46 (0)736 840 523
Anders Atterling, IR & PR manager, Semcon AB, +46 (0)704 472 819